Evaluating Diagnostic and Treatment Timelines for ALK-Positive NSCLC Patients: Results From a Global Registry. Bazzi H, Thuo N, Sravanam S, Chen W, et al. Clin Lung Cancer 2025;26:470-477.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bazzi H, Thuo N, Sravanam S, Chen W, et al. Evaluating Diagnostic and Treatment Timelines for ALK-Positive NSCLC Patients: Results From a Global Registry. Clin Lung Cancer 2025;26:470-477.
PMID: 40617736